✦ LIBER ✦

Hormone replacement therapy and cardiovascular risk

✍ Scribed by Marie Gerhard-Herman; Naomi Hamburg; Peter Ganz

Book ID: 107534713
Publisher: Springer
Year: 2000
Tongue: English
Weight: 177 KB
Volume: 2
Category: Article
ISSN: 1523-3782
DOI: 10.1007/s11886-000-0083-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of hormone replacement therapy o

Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women

✍ Banu Bingol; Ziya Gunenc; Murat Yilmaz; Aydan Biri; Bülent Tiras; Haldun Güner 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 294 KB

Risks and Benefits of Hormone Replacemen

Risks and Benefits of Hormone Replacement Therapy

✍ Theodore A. Kotchen; George Mansour; Janette Mansour 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 126 KB

Hormone replacement therapy and lung can

Hormone replacement therapy and lung cancer risk in Chinese

✍ Kuan-Yu Chen; Chin-Fu Hsiao; Gee-Chen Chang; Yin-Huang Tsai; Wu-Chou Su; Reury-P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co

Hormone replacement therapy

✍ Teake Kooistra; Jef J Emeis 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic. The availabilit

Primary and secondary prevention of card

Primary and secondary prevention of cardiovascular events through hormone replacement therapy

✍ Heidemarie Pilz 📂 Article 📅 2005 🏛 Springer Vienna 🌐 German ⚖ 755 KB

Risk of cancer in women receiving hormon

Risk of cancer in women receiving hormone replacement therapy

✍ Hans-Olov Adami; Ingemar Persson; Robert Hoover; Catharine Schairer; Leif Bergkv 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 828 KB

Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed